Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: A clinicopathological investigation of 41 cases

Histopathology

Volumn 59, Issue 4, 2011, Pages 741-750

  Weiler, Christoph ^a   Zengel, Pamela ^b   van der Wal, Jacqueline E ^c   Guntinas Lichius, Orlando ^d   Schwarz, Stephan ^e   Harrison, John D ^f   Kirchner, Thomas ^a   Ihrler, Stephan ^a,g  

^a Institute of Pathology   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g Laboratory for Dermatohistology and Oral Pathology   (Germany)

Author keywords

Carcinoma ex pleomorphic adenoma; Intraductal carcinoma; Pleomorphic adenoma; Prognosis; Recurrence; Salivary gland carcinoma; Salivary gland disease

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOMA; CARCINOMA EX PLEOMORPHIC ADENOMA; CLINICAL ARTICLE; DISEASE COURSE; EXTRACAPSULAR CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MALE; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SURVIVAL RATE;

ADENOMA, PLEOMORPHIC; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; SALIVARY GLAND NEOPLASMS;

EID: 80054945862     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03937.x     Document Type: Article

References (21)

1. Gnepp DR, Brandwein-Gensler MS, El-Naggar AK, Nagao T. Carcinoma ex pleomorphic adenoma. In Barnes L, Eveson JW, Reichart P, Sidransky D eds. Pathology and genetics of head and neck tumours. Lyon: IARC Press, 2005; 242-243.
2. LiVolsi VA, Perzin KH. Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer 1977; 39; 2209-2230.
3. Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol. Annu. 1993; 28(Pt 1); 279-328.
4. Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck 2001; 23; 705-712.
5. Ihrler S, Weiler C, Hirschmann A et al. Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53. Histopathology 2007; 51; 362-371.
6. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum. Pathol. 2001; 32; 596-604.
7. Altemani A, Martins MT, Freitas L, Soares F, Araujo NS, Araujo VC. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology 2005; 46; 635-641.
8. Di Palma S, Skalova A, Vanieek T, Simpson RH, Starek I, Leivo I. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry. Histopathology 2005; 46; 144-152.
9. Hashimoto K, Yamamoto H, Shiratsuchi H et al. S100P expression in ductal type of carcinoma ex pleomorphic adenoma. Am. J. Surg. Pathol. 2011; 35; 346-355.
10. Tortoledo ME, Luna MA, Batsakis JG. Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes. Arch. Otolaryngol. 1984; 110; 172-176.
11. Brandwein M, Huvos AG, Dardick I, Thomas MJ, Theise ND. Noninvasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1996; 81; 655-664.
12. Katabi N, Gomez D, Klimstra DS, Carlson DL, Lee N, Ghossein R. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases. Hum. Pathol. 2010; 41; 927-934.
13. Stennert E, Wittekindt C, Klussmann JP, Arnold G, Guntinas-Lichius O. Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study. Laryngoscope 2004; 114; 158-163.
14. Leonetti JP, Marzo SJ, Petruzzelli GJ, Herr B. Recurrent pleomorphic adenoma of the parotid gland. Otolaryngol. Head Neck Surg. 2005; 133; 319-322.
15. Wittekindt C, Streubel K, Arnold G, Stennert E, Guntinas-Lichius O. Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients. Head Neck 2007; 29; 822-828.
16. Zbaren P, Stauffer E. Pleomorphic adenoma of the parotid gland: histopathologic analysis of the capsular characteristics of 218 tumors. Head Neck 2007; 29; 751-757.
17. Ihrler S, Zietz C, Sendelhofert A, Lang S, Blasenbreu-Vogt S, Lohrs U. A morphogenetic concept of salivary duct regeneration and metaplasia. Virchows Arch. 2002; 440; 519-526.
18. Ihrler S, Sendelhofert A, Weiler C, Hagedorn H, Harrison JD. Preinvasive intraductal neoplasia in salivary adenocarcinoma, not otherwise specified. Virchows Arch. 2006; 449; 159-163.
19. Ihrler S, Schwarz S, Zengel P, Guntinas-Lichius O, Kirchner T, Weiler C. Das pleomorphe Adenom. Pitfalls in der Diagnostik und klinisch-pathologische Progressionsformen [Pleomorphic adenoma: pitfalls and clinicopathological forms of progression]. Pathologe 2009; 30; 446-456.
20. Di Palma S, Corletto V, Lavarino C, Birindelli S, Pilotti S. Dedifferentiation in salivary gland carcinomas. Am. J. Surg. Pathol. 2000; 24; 1439-1440.
21. Spiro RH, Huvos AG, Strong EW. Malignant mixed tumor of salivary origin: a clinicopathologic study of 146 cases. Cancer 1977; 39; 388-396.